Prime Meridian Income Fund

AlphaCentric Prime Meridian Fund (PMIFX)
Marketplace Lending: An Alternative Income Opportunity

Internet technology is creating new opportunities for investors to participate in the enormous and potentially profitable online credit market that has historically been the exclusive territory of a few large banks.

PMIFX seeks to provide current income yield to investors by managing a diversified portfolio of Consumer, Small Business and Real Estate loans.

Potential Investor Advantages:

  • Access to a rapidly growing $40B direct lending marketplace.
  • Strong yields historically only available to banks and credit card companies and other institutions.
  • Professional management by Prime Meridian Capital, with a proven history of managing a family of pure-play debt income funds.
  • One professionally managed fund to invest in 3 types of marketplace loans:
    • Real Estate Loans
    • Consumer Loans
    • Small Business Loans

Fund Commentary

Commentary | Q2 2020

Commentary | Q3 2020

Energy Income Fund

AlphaCentric Energy Income Fund (AEIAX | AEICX | AEIIX)
Growth and Income: The Energy Transition Opportunity

Objective: The Fund’s investment objective is total return with an emphasis on current income.

Takes advantage of the trends behind the rapidly increasing demand for electricity by investing in hard assets with predictable cashflows and steady yield of companies best positioned to participate in that growth.

Potential investor benefits:

  • Targets attractive monthly income through exposure to stable cash flow streams via investments in infrastructure equity and credit in both fossil fuel and renewable energy.
  • Access to the megatrend of renewable energy infrastructure spending growth.
  • Lower correlations to broader markets and lower volatility potential via a mix of infrastructure investments.
  • A fund that invests across the capital structure and infrastructure landscape.
  • Sub-advised by Kayne Anderson, a leading alternatives investments manager with a strong track record of success in the Energy Infrastructure space
Municipal Opportunities Fund

AlphaCentric Municipal Opportunistic Fund (MUNAX | MUNCX | MUNIX)
A Boutique Advantage for Growth with Tax-Free Income 

The Fund seeks to produce above average Tax-Exempt income and to protect investors in periods of volatile interest rate movements and spread widening.

Potential Benefits Include:

  • Tax-Free Income Stream – created using the full spectrum of available tax- free securities
  • Capital Appreciation Potential –  using a time-tested trend following interest rate overlay
  • Broader Mandate & Flexibility – leverages the investment expertise of top traders and quantitative modeling
LifeSci Healthcare Fund

A Share: LYFAX, C Share: LYFCX, I Share: LYFIX

Objective: The Fund’s investment objective is long-term capital appreciation.

The AlphaCentric LifeSci Healthcare Fund Leverages the experience of 20+ PhDs and MDs combined with the hands-on scientific achievements of Portfolio Manager, Mark Charest to invest in Biotech and Healthcare equities to capture long term capital appreciation through fundamental, thesis-driven investments.

The LifeSci Healthcare Fund Difference:

Investment Strategy

  • Designed to outperform broad market exposure by investing in Life Sciences and Healthcare equities leveraging proprietary primary research
  • Emphasizes Science-driven biotechnology and pharmaceutical companies addressing high unmet medical needs

Experienced Team

  • Award winning scientists who have transitioned to successful professional investors..
  • Lead Portfolio Manager Mark G. Charest, Ph.D. has a distinguished scientific background and more than a decade of institutional healthcare investing experience
  • More than a decade of collaboration experience working with LifeSci Partners

Life Sci Platform:

  • Since 2009, LifeSci Partners has been a leading provider of strategic scientific consulting services for innovative healthcare companies
  • Global presence with more than 100 investment and science professionals including 20+ PhD.s and MDs

About the Portfolio Manager:

Mark G. Charest, Ph.D.

Mark is an inventor on 8 drug patents who also has a successful career as a healthcare investor at several specialized $1B+ AUM healthcare technology funds. He led a Medicinal Chemistry Lab at the Novartis Institutes for BioMedical Research after earning his Ph.D. in chemistry and chemical biology from Harvard University.

He is a National Science Foundation Graduate Research Fellow, with an MS in chemistry and chemical biology from Harvard University. His distinguished career includes the completion of noble prize winning chemist RB Woodward’s work on chemical synthesis of tetracycline. This work was critical in the creation of an approved drug to treat complicated intra-abdominal infections. After successfully running a lab at Novartis which included successfully putting a drug into clinical trials. Mark transitioned to Wall Street in 2007.

He has held positions as an SVP at Tekla Capital Management, a Portfolio Manager at New Leaf Venture Partners and an Associate at Great Point Partners. Mark was a Kauffman Fellow at Panorama Capital where he served on the board of directors of Itero Biopharmaceuticals and was a board observer at Presidio Pharmaceuticals and PowerVision.

Premium Opportunity Fund

A Share: HMXAX, C Share: HMXCX, I Share: HMXIX

Objective: 1. The Fund’s objective is to achieve long-term capital appreciation.

Primary Goals and Key Reasons to Invest:

1. Capital Appreciation: The Fund seeks to provide capital appreciation in all market conditions. Since inception, the Fund has weathered volatile financial markets without large drawdowns.
2. Low Correlation: The Fund seeks returns that are uncorrelated to equity markets through a strategy that profits from options time decay, changes in options volatility, options volatility arbitrage, and price and options volatility mean reversion.

Minimum Investment: $2,500, Subsequent Investment: $100

Income Opportunities Fund

A Share: IOFAX, C Share: IOFCX, I Share: IOFIX

Objective: To achieve current income and total return by implementing an alpha-driven, “principles-based” investment process focusing on complex and hard to source asset-backed securities.

Primary Goals and Key Reasons to Invest:

  1. Non-Agency RMBS Focus: The Fund focuses on non-agency residential mortgage-backed securities (RMBS), although the Fund can invest where management finds value. The management team’s clearly-defined, niche focus is the core of the RMBS strategy’s success.
  2. Strong Track Record*: The Sub-Advisor has managed a substantially similar strategy that has consistently met its objective of current income while outperforming its benchmark.
  3. Private Asset Backed Exposure: Unique sourcing to high coupon, well-capitalized proprietary deal flow may lead to additional alpha.

Alpha: A measure of the difference between a fund’s actual returns and its expected performance, given its level of risk as measured by beta.

* See Prospectus for historical performance. Past performance is no guarantee of future results.

Minimum Investment: $2,500, Subsequent Investment: $100

Robotics and Automation Fund

A Share: GNXAX, C Share: GNXCX, I Share: GNXIX

Objective: To achieve long‐term growth of capital.

Primary Goals and Key Reasons to Invest:

  • Global Growth Opportunity: We believe growth in robotics for workplace automation has reached a tipping point towards wide-scale adoption Global spending on robotics is rapidly expanding.
  • Thematic Investment Opportunity: The AlphaCentric Robotics and Automation Fund (GNXAX) is the first actively managed mutual fund dedicated to automation and robotics. The Fund is diversified by company industry sector country market capitalization and style and acts as a complement to a diversified equity portfolio.
  • Long-term Growth of Capital: The Fund employs proprietary, bottom up research to identify companies worldwide with innovation technologies such as robotics and automation companies and potential for long‐term out-performance.
  • Disciplined Strategy: The Fund will concentrate its investments (i.e. invest more than 25% of its assets) in the machinery and electrical equipment industries. The Fund may invest without limit in companies located anywhere in the world and under normal conditions at least 40% of the Fund’s assets will be in securities of issuers domiciled in at least countries outside of the United States.

Minimum Investment: $2,500, Subsequent Investment: $100

Symmetry Strategy Fund

A Share: SYMAX, C Share: SYMCX, I Share: SYMIX

Objective: The Fund’s investment objective is capital appreciation.

The AlphaCentric Symmetry Strategy Fund utilizes a specifically constructed and repeatable set of investment building blocks designed to capture the available risk premiums during periods of broad economic growth, as well as during periods of economic growth risk.

Investment Strategy

The Fund may invest up to 80% of assets in the Traditional Component Strategy and up to 50% of assets in the Alternative Component Strategy. Under normal conditions, assets will be allocated to each strategy in substantially equal risk adjusted proportions.

Traditional Component Strategy

The Traditional Component Strategy seeks to capture returns that have been historically associated with risk premiums (i.e., the difference between expected return on investment and risk-free rate) for investing in equity and debt securities.

This strategy is expected to benefit from periods of economic growth.

Alternative Component Strategy

The Alternative Component Strategy seeks to capture returns from short term dislocations in currency, interest rate and commodity markets.

The strategy is expected to benefit from periods of economic uncertainty and risk.

Minimum Investment: $2,500, Subsequent Investment: $100